Related references
Note: Only part of the references are listed.A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: A secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data
Wendy L. St. Peter et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
C Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study
EW Young et al.
KIDNEY INTERNATIONAL (2005)
Effect of MCI-196 (colestilan) as a phosphate binder on hyperphosphataemia in haemodialysis patients: a double-blind, placebo-controlled, short-term trial
S Kurihara et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis
GA Block et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
The need for better control of secondary hyperparathyroidism
F Locatelli
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Achieving K/DOQI laboratory target values for bone and mineral metabolism: An uphill battle
Z Al Aly et al.
AMERICAN JOURNAL OF NEPHROLOGY (2004)
Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE study)
WY Qunibi et al.
KIDNEY INTERNATIONAL (2004)
Arterial media calcification in end-stage renal disease:: impact on all-cause and cardiovascular mortality
GM London et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
A prospective study of combination therapy for hyperphosphataemia with calcium-containing phosphate binders and sevelamer in hypercalcaemic haemodialysis patients
CW McIntyre et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
GM Chertow et al.
KIDNEY INTERNATIONAL (2002)
Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia
F Locatelli et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
Consequences of hyperphosphatemia and elevated levels of the calcium-phosphorus product in dialysis patients
NW Levin et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2001)
Arterial stiffening and vascular calcifications in end-stage renal disease
AP Guérin et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2000)
Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
WG Goodman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
